Netherlands· NL-ab3bb24eec86
Modafinil 200 mg Focus, tabletten
A modafinil product containing modafinil, registered in Netherlands by Focus Care Pharmaceuticals B.V.. The same ATC class is registered in 17 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Modafinil is registered in 17 of 19 countries.
Countries holding a registration under ATC N06BA07 (modafinil), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 10 of them publish a price we can compare per daily dose
Modafinil · ATC N06BA07
17 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of modafinil costs, country by country.
Normalised to the WHO defined daily dose (0.3 g), the median price runs from $4.39 in France to $10.18 in Italy — a ×2.3 gap.
- 3 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Modafinil · price per daily dose (0.3 g)
USD · FX 28 Sept 2026
- IT Italy$10.18
- CH Switzerland$6.31
- FR France$4.39
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- MODAFINIL
- Manufacturer
- Focus Care Pharmaceuticals B.V.
- Country
- Netherlands (NL)
- ATC code
- N06BA07
- ATC class
- Modafinil
- Defined daily dose
- 0.3 g, O
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_id115163
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
360 interactions on record for modafinil.
Graded by severity as the source publishes them — 31 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Modafinil · interactions on record
360 records
- 31 severe
- 128 moderate
- 103 minor
- 98 info
Most severe, free to view
- DeflazacortH02AB13severe
- BosutinibL01EA04severe
- EncorafenibL01EC03severe
- BrigatinibL01ED04severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Modafinil in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesmodafinilAphena Pharma Solutions - Tennessee, LLC
- United KingdomModafinil 200mg tabletsZentiva Pharma UK Ltd
- IrelandModafinil Bluefish 200 mg tabletsBluefish Pharmaceuticals AB
- FinlandModafinil OrchidOrchid Europe Ltd
- PolandActimodanAflofarm Farmacja Polska Sp. z o.o.
- SwedenModafinil Orion 200 mg TablettOrion Corporation
- CzechiaASPENDOSMedochemie Ltd., Limassol
- FranceMODAFINIL ARROW 100 mg, compriméARROW GENERIQUES
Authorised across Europe · EMA
The same active substance is authorised in 23 EEA countries. Names it is sold under:
- Austria · Modafinil Aristo, Modasomil
- Belgium · Provigil
- Bulgaria · Аспендос
- Cyprus · Aspendos, Modiodal
- Czechia · Aspendos, Vigil
- Germany · Modafinil Aristo, Modafinil Aurobindo
- Denmark · Modafinil, Modafinil Orifarm
- Spain · Modafinilo Aristo, Modafinilo Aurovitas
- Finland · Modafinil Orion
- France · Modafinil Arrow, Modafinil Biogaran
- United Kingdom (Northern Ireland) · Modafinil, Modafinil Dawa
- Greece · Aspendos
- Croatia · Vigifinil
- Ireland · Modafinil Bluefish, Modafinil Forza
- Iceland · Aspendos, Myldamo
- Italy · Provigil
- Luxembourg · Provigil
- Norway · Modiodal
- Poland · Actimodan
- Portugal · Modafinil Forza, Modafinil Generis
- Romania · Aspendos
- Sweden · Modafinil Forza, Modafinil Orifarm
- Slovakia · Aspendos
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/15eeddda-8d1d-4bc1-be4b-b82fa1700d4d GET /v1/drugs/15eeddda-8d1d-4bc1-be4b-b82fa1700d4d?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tablet",
"route": "Oraal gebruik",
"soort": "RVG",
"source": "cbg_meb",
"smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h115163_smpc.pdf",
"strength": null,
"atc_label": "Modafinil",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg115163",
"excipients": [
"CROSPOVIDON (E 1202)",
"LACTOSE 0-WATER",
"LACTOSE 1-WATER",
"NATRIUMSTEARYLFUMARAAT",
"POVIDON K 30 (E 1201)",
"SILICIUMDIOXIDE (E 551)",
"TALK (E 553b)"
],
"substances": [
"MODAFINIL"
],
"leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h115163.pdf",
"authorised_at": "2015/06/19",
"procedure_number": "IE/H/1088/002",
"dispensing_status": "Uitsluitend recept",
"registration_number": "115163",
"additional_monitoring": "N"
}See everything about modafinil.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.